Dermatology in the future: Access to the right drug will be a global challenge
Conducted by Dr Susanne Kammerer
President of the American Academy of Dermatology, Adjunct Professor at St Louis University, and Director of the Laser & Dermatologic Surgery Center in St Louis, USA.
Prof. Hruza, what are your highlights of this AAD meeting?
This is a though question. About 18,000-20,000 people came to the meeting, including 9,500 medical professionals and a huge international presence. Talks are all about the new stuff, like the biologic drugs enabling us to treat inflammatory diseases such as psoriasis and atopic dermatitis better than ever before. There are also exiting new ...
Please login to read the full text of the article.
If you have no account yet, please register now.
« Secukinumab maintains improvements in psoriasis through 5 years of treatment Next Article
Letter from the Editor »